The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investee Company Update: Entertainment Direct Asia

23 Apr 2020 15:15

RNS Number : 6992K
FastForward Innovations Limited
23 April 2020
 

FastForward Innovations Ltd / AIM: FFWD / Sector: Closed End Investments

23 April 2020

FastForward Innovations Ltd

("FastForward", "FFWD" or the "Company")

 

Investee Company Update: Entertainment Direct Asia Ltd

 

FastForward Innovations Ltd, the AIM quoted company focusing on making investments in fast growing and industry leading businesses, hereby provides an update in respect of investee company, Entertainment Direct Asia Ltd ("EDA"), which trades as Yooya Media.

 

Further to the announcement dated 20 March 2020, FastForward announces that, together with all EDA shareholders, it has agreed to transfer its shares in EDA to Yooma Corp. ("Yooma") pursuant to a share for share exchange agreement (the "Share Exchange"). The Share Exchange gives an implied value of approximately US$2.25 per share (preferred and common stock), valuing EDA at, in aggregate, US$390,000.

 

Following the Share Exchange, the Company will hold 7.88 per cent. of the enlarged issued share capital of Yooma. The Company's interest in Yooma has an implied value of US$61,500 based on the terms of the Share Exchange compared to a carrying value in the Company's books of EDA of £1,586,000 as per the Interim financial statements dated 30 September 2019.

 

Yooma intends to be an Asia-focused social commerce platform company having built a strong management team with a capital markets background. Whilst it is the stated intention of Yooma to raise funds at a significant premium to the implied price of the Share Exchange, any future funding for Yooma is based on the combined business achieving milestones to justify any uplift in valuation. The impact on the longer term carrying value will depend on the final terms of any fundraising by Yooma and the resulting success of the business; such valuation of its interest in Yooma will be reviewed by the Company at the time it prepares its annual accounts for the year ended 31 March 2020.

 

In addition, it is expected that Lorne Abony, the Company's Chairman, will join the board of Yooma as a Non-Executive Director to assist with the implementation of their business strategy.

 

Further updates regarding the business and operations of Yooma will be released by the Company as and when material milestones are achieved.

 

FastForward Chairman, Lorne Abony, said, "FastForward supports the acquisition of EDA by Yooma. While it is disappointing that the Share Exchange is being undertaken at a significant discount to the carrying value of the Company's interest in EDA, we believe that Yooma, upon raising additional funds, will have the opportunity to build a position as a trusted e-commerce platform for consumers across China, and subsequently more widely across Asia."

 

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014.

 

Cautionary Statement

The AIM Market of London Stock Exchange plc does not accept responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. All statements, other than statements of historical fact, in this news release are forward-looking statements that involve various risks and uncertainties, including, without limitation, statements regarding potential values, the future plans and objectives of FastForward Innovations Ltd. There can be no assurance that such statements will prove to be accurate, achievable or recognizable in the near term.

 

Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. FastForward Innovations assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change.

 

*** ENDS***

 

For further information on the Company please visit www.fstfwd.co or contact:

Ed McDermott / Lance de Jersey

FastForward Innovations Ltd

Email: info@fstfwd.co

 

James Biddle / Roland Cornish

Beaumont Cornish Limited,

Nomad

 

Tel: +44 (0) 207 628 3396

 

Graham Dickson

Optiva Securities Limited,

Broker

 

Tel: +44 (0) 203 411 1881

 

Isabel de Salis / Beth Melluish

St Brides Partners Ltd,

Financial PR

 

Tel: +44 (0)207 236 1177

 

Notes

FastForward innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDEALLDAEDEEFA
Date   Source Headline
6th Apr 20167:00 amRNSInvestee Company Update
5th Apr 20162:50 pmRNSInvestee Company Update
4th Apr 20167:00 amRNSInvestee Company Update: Schoold
31st Mar 20161:18 pmRNSInvestee Company Update
9th Mar 201610:00 amRNSExpected announcement date of 2016 Final Results
4th Mar 201610:01 amRNSInvestee Company Update
3rd Mar 20165:15 pmRNSInvestee Company Update: Vemo
19th Feb 20167:00 amRNSGrant of Options
18th Feb 20168:21 amRNSHolding(s) in Company
15th Feb 20165:23 pmRNSTransaction in Own Shares
15th Feb 20161:26 pmRNSFurther Investment in Yooya
12th Feb 20165:19 pmRNSCompletion Placing
8th Feb 20166:20 pmRNSPlacing Update
2nd Feb 20167:00 amRNSInvestee Company Update
28th Jan 20167:00 amRNSPlacing
27th Jan 20164:47 pmRNSLorne Abony Appointed as Chief Executive Officer
26th Jan 20167:00 amRNSInvestment
11th Jan 20164:27 pmRNSHolding(s) in Company
11th Jan 201612:33 pmRNSInvestment in Yooya Media
6th Jan 20161:47 pmRNSDirectorate Change
5th Jan 20165:19 pmRNSCompletion of investment in VEMO and Placing
29th Dec 20157:00 amRNSNew Website
22nd Dec 20153:08 pmRNSPlacing and Director Dealing
21st Dec 20155:56 pmRNSAcquisition of shares in Vemo Education, Inc
17th Dec 20154:00 pmRNSDBC receives US FDA approval to market PulseFlowDF
17th Dec 20157:00 amRNSInvestee Company Update - Vemo Education Inc
2nd Dec 20154:26 pmRNSHolding(s) in Company
26th Nov 201511:02 amRNSPlacing
25th Nov 20157:00 amRNSInvestee Company Update - Vemo Education Inc
23rd Nov 20156:05 pmRNSHolding(s) in Company
23rd Nov 201511:36 amRNSResult of General Meeting
23rd Nov 20157:00 amRNSAcquisition
13th Nov 20157:00 amRNSHalf Yearly Report
10th Nov 20151:32 pmRNSPlacing
3rd Nov 20157:00 amRNSProposed Name Change
29th Oct 20157:00 amRNSCorporate Update
22nd Oct 20153:35 pmRNSInvestee company Intensity Therapeutics update
14th Oct 20157:53 amRNSInvestment in Factom
6th Oct 20158:03 amRNSInvestment in Intensity Therapeutics Inc
21st Sep 20157:00 amRNS10% Acquired of nanopayment developer SatoshiPay
18th Sep 201510:32 amRNSResult of AGM
8th Sep 20157:00 amRNSIssue of Equity
7th Sep 20157:00 amRNSAcquisition
1st Sep 20157:03 amRNSIssue of Equity
31st Jul 20158:24 amRNSUpdate on Investment review
28th Jul 201511:36 amRNSResult of EGM
13th Jul 20158:00 amRNSChange of Investing Policy and Name
13th Jul 20157:00 amRNSDirectorate Change
23rd Jun 20152:36 pmRNSNotice of AGM
17th Jun 20159:34 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.